Business
Royal Oldham Hospital Agreement
Royal Oldham Hospital Agreement.
About this update from Creo Medical Group Plc
[{"type":"text","content":"\n\n \nCreo Medical Group plc\n(\"Creo\" the \"Company\" or the \"Group\")\n \nThe Royal Oldham Hospital becomes first NHS hospital to immediately implement CROMA and Speedboat™ Inject across multiple Endoscopy rooms\nMultiple doctors already working through regular weekly SSD lists after significant order \n \nCreo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of surgical endoscopy, announces that The Royal Oldham Hospital is the latest NHS England hospital to become a high-volume site for Speedboat Inject, with the device supporting their goal to prevent and treat bowel cancer.\n \nHaving recently completed simultaneous training of multiple doctors through Creo's Pioneer clinical education and mentoring programme, the hospital has quickly ordered and taken delivery of several CROMA Advanced Energy platforms, Speedboat Inject devices and associated endotherapy products, before putting in place weekly lists for multiple SSD (Speedboat Submucosal Dissection) cases and the associated routine ordering of equipment to support these services.\n \nAs part of Creo's Pioneer Clinical Education Programme in late April, three doctors at the Royal Oldham each performed their first in-hospital SSD procedures using Speedboat Inject, with a total of five cases successfully completed during a single afternoon. The Royal Oldham's CEO and Managing Director of Surgery were present to witness Creo's technology and the hospital's endoscopy team has since successfully performed over a dozen further cases. The service has been supported by high quality mentoring from Creo Medical, enabling new trainees to transition easily into regular users.\n \nCreo Medical expects to see continued high usage by the three new physicians as they support the Trust as it tackles NHS waiting lists cost effectively. SSD has already provided savings of up to £10k per procedure compared to the surgical alternative. Most importantly, this should help hundreds of patients per year to avoid more invasive procedures and the complications that can come with them. \n \nThe Royal Oldham Hospital is the twenty-third NHS England healthcare setting to adopt SSD, with twelve now high-volume users. Creo Medical conservatively estimates that there are over 350 hospitals in the UK wh...